Zhang Yuan, Chen Xu, Zhao Yanfang, Ponnusamy Murugavel, Liu Ying
.
Rev Neurosci. 2017 Nov 27;28(8):861-868. doi: 10.1515/revneuro-2017-0013.
Alzheimer's disease (AD) is the most common neurodegenerative disorder leading to dementia in the elderly population. AD is associated with the buildup of β-amyloid and tau, which aggregate into extracellular plaques and neurofibrillary tangles. Although the exact mechanism of pathological process of AD is unclear, the dysfunction of protein degradation mechanisms has been proposed to play an important role in AD. The cellular degradation of abnormal or misfolded proteins consists of three different mechanisms: the ubiquitin proteasomal system (UPS), autophagy-lysosomal pathway (ALP), and interaction of molecular chaperones with UPS or ALP. Any disturbance to these systems causes proteins to accumulate, resulting in pathological process of AD. In this review, we summarize the knowledge of protein degradation pathways in the pathogenesis of AD in light of the current literature. In the future, the regulation UPS or ALP machineries could be the cornerstones of the treatment of AD.
阿尔茨海默病(AD)是导致老年人群痴呆的最常见神经退行性疾病。AD与β-淀粉样蛋白和tau蛋白的积累有关,这些蛋白会聚集形成细胞外斑块和神经原纤维缠结。尽管AD病理过程的确切机制尚不清楚,但有人提出蛋白质降解机制的功能障碍在AD中起重要作用。异常或错误折叠蛋白质的细胞降解由三种不同机制组成:泛素蛋白酶体系统(UPS)、自噬-溶酶体途径(ALP)以及分子伴侣与UPS或ALP的相互作用。这些系统中的任何干扰都会导致蛋白质积累,从而引发AD的病理过程。在本综述中,我们根据当前文献总结了蛋白质降解途径在AD发病机制中的相关知识。未来,调节UPS或ALP机制可能是AD治疗的基石。